Active

Newton Biocapital Partners

Switched

BE0673852565

Rechtspersoon Private limited company 1 establishment

Tervurenlaan 273, 1150 Sint-Pieters-Woluwe Overige financiële dienstverlening, neg

Active for

9 year, 5 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ -8,515

▼ 114% vs 2024

Profit

Caution

€ -15,120

▼ 152% vs 2024

Debts

Normal

€ 204,311

▲ 10% vs 2024

Newton Biocapital Partners from Sint-Pieters-Woluwe, company number BE0673852565, closed financial year 2025 with a result of € -15,120 after tax. For that financial year Newton Biocapital Partners recorded a gross margin of € -8,515 and equity of € 36,300. Compared with financial year 2024, the result moved from € 28,818 to € -15,120. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.

What happened at Newton Biocapital Partners?

What happened at Newton Biocapital Partners in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 15,120 (▼ 152% vs 2024). Source: NBB ↗
  • HEYNEN CONSULTING AG became a director. NBB
  • New establishment in Sint-Pieters-Woluwe. KBO
  • A Q INVEST SRL became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 106,622 profit in 2021 to € 15,120 loss in 2025.

Paid € 107,873 in corporate taxes since 2021.

Best year ever: 2021, with € 106,622 profit.

A new publication or filing at Newton Biocapital Partners? We notify you, reason included.

Follow Newton Biocapital Partners

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Newton Biocapital Partners
NEWTON BIOCAPITAL PARTNERS GODO KAISHA 100%

Behind Newton Biocapital Partners are HEYNEN CONSULTING AG and A Q INVEST SRL. It owns 100% of NEWTON BIOCAPITAL PARTNERS GODO KAISHA itself.

See the full network in the app

Directors

According to the 2025 annual accounts

HEYNEN CONSULTING AG

Director · represented by Guillaume HEYNEN

Also active at: Newton Biocapital II Partners

since 2021

A Q INVEST SRL

Director · represented by Alain PARTHOENS

Also active at: Ncardia Holding, Newton Biocapital I Investment Pool, DEXOWL +1 more

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Tervurenlaan 273

1150 Sint-Pieters-Woluwe

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0673.852.565
VAT number
BE 0673.852.565
Registered office
Tervurenlaan 273, 1150 Sint-Pieters-Woluwe
Names & denominations
Newton Biocapital Partners
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
4 April 2017
Peppol
Active · Active since 29 Jan 2026
Activities · NACE

Overige financiële dienstverlening, neg

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What is the enterprise number of Newton Biocapital Partners?
The enterprise number of Newton Biocapital Partners is BE0673852565.
What is the address of Newton Biocapital Partners?
The registered office of Newton Biocapital Partners is located at Tervurenlaan 273, 1150 Sint-Pieters-Woluwe.
When was Newton Biocapital Partners founded?
Newton Biocapital Partners was founded on 4 April 2017.
What is the main activity of Newton Biocapital Partners?
The main activity of Newton Biocapital Partners is "Overige financiële dienstverlening, neg" (NACE code 64999).
Does Newton Biocapital Partners have a website?
No website is currently known for Newton Biocapital Partners.
How much profit did Newton Biocapital Partners make in 2025?
Newton Biocapital Partners recorded a loss after taxes of € 15,120 in financial year 2025.
What is the revenue of Newton Biocapital Partners?
As a small company, Newton Biocapital Partners is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -8,515.
Where can I find the annual accounts of Newton Biocapital Partners?
Newton Biocapital Partners files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Newton Biocapital Partners?
According to the 2025 annual accounts, the directors of Newton Biocapital Partners are: HEYNEN CONSULTING AG, A Q INVEST SRL.
Who owns Newton Biocapital Partners?
Behind Newton Biocapital Partners are HEYNEN CONSULTING AG and A Q INVEST SRL. It owns 100% of NEWTON BIOCAPITAL PARTNERS GODO KAISHA itself.